Aim immunotech board files definitive proxy statement and sends letter to shareholders

Ocala, fla.--(business wire)--the board of directors (“board”) of aim immunotech inc. (nyse: american aim) (“aim” or the “company”), today announced that the company has filed its definitive proxy statement in connection with aim's upcoming 2022 annual meeting of stockholders (the “annual meeting”), to be held on november 3, 2022, and has mailed this statement, along with a letter, to shareholders. the full text of the letter follows. september 19, 2022 dear fellow shareholders: thank you for y
AIM Ratings Summary
AIM Quant Ranking